Solid Biosciences Inc SLDB Q1 2026 Earnings Wider Loss Reported as Pipeline Investment Continues NTRB Q1 2026 Earnings Massive EPS Beat Highlights Cost Control Amid PreRevenue Stage BOX Q1 2026 Earnings EPS Slightly Beats Estimates Amid Modest Stock Pullback Chevron Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiencies TransAct Technologies TACT Q1 2026 Earnings Surprise Profitability as EPS Beats Estimates by Wide Margin Solidion Technology Q4 2025 Earnings Continued Losses Amidst No Revenue